HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Petersen, R. Articles by Pedersen, S. Search for Related Content PubMed PubMed Citation Articles by Petersen, R. Articles by Pedersen, S.

Treatment of exercise-induced asthma with beclomethasone dipropionate in children with asthma

Dept of Paediatrics, Kolding Hospital, Kolding, Denmark

CORRESPONDENCE: R. Petersen, Dept of Paediatrics, Kolding Hospital, 6000 Kolding, Denmark. Fax: 45 75535222. E-mail: sumsar68@hotmail.com

Keywords: Asthma, children, dose response, exercise, hydrofluoroalkane-beclomethasone dipropionate, nitric oxide

Received: December 23, 2003
Accepted July 23, 2004

This study was supported by 3M Pharmaceuticals, St. Paul, MN, USA.

A new hydrofluoroalkane-beclomethasone dipropionate (HFA-BDP) aerosol markedly increases drug delivery to the airways. Therefore, even low doses of HFA-BDP should be effective, and the present study assesses this.

A randomised, double-blind, crossover study was used to compare the effect of placebo, HFA-BDP 50 µg or 100 µg given q.d. (QVAR^TM Autohaler^TM; 3M Pharmaceuticals, St. Paul, MN, USA) on exercise-induced bronchoconstriction and exhaled nitric oxide (eNO). After a 14-day run-in, 25 children (5–14 yrs old) entered three 4-week treatment periods, separated by a 1-week washout. After each period, the fall in forced expiratory volume in one second (FEV₁), after an exercise test, and eNO were measured.

Significant treatment effects with no carry-over or period effects were seen for both eNO and maximum fall in FEV₁ after exercise. Differences were seen between placebo (fall in FEV₁=27.9%; eNO=14.4 parts per billion (ppb)) and either dose of HFA-BDP, but not between the two active doses (50 µg: fall in FEV₁=20.8%, eNO=9.3 ppb; 100 µg: fall in FEV₁=20.9%, eNO=8.9 ppb).

In conclusion, low q.d. doses of hydrofluoroalkane-beclomethasone dipropionate reduced exhaled nitric oxide and exercise-induced bronchoconstriction. Further studies are needed to assess whether q.d. administration of beclomethasone dipropionate is as effective as b.i.d. administration.

This article has been cited by other articles:

				H W. Kelly Comparison of Inhaled Corticosteroids: An Update Ann. Pharmacother., March 1, 2009; 43(3): 519 - 527. [Abstract] [Full Text] [PDF]

				M. Duong, P. Subbarao, E. Adelroth, G. Obminski, T. Strinich, M. Inman, S. Pedersen, and P. M. O'Byrne Sputum Eosinophils and the Response of Exercise-Induced Bronchoconstriction to Corticosteroid in Asthma Chest, February 1, 2008; 133(2): 404 - 411. [Abstract] [Full Text] [PDF]